PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...
VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. announced today that the first commercial procedure of StimRouter ™ Neuromodulation System has been performed under the company’s FDA clearance to ...
“We believe the new Category I CPT codes will enable more predictable and consistent reimbursement for Barostim patients and healthcare professionals,” said Kevin Hykes, President and Chief Executive ...
New data from the United States bolster the case for dementia prevention. At the same time, noninvasive stimulation procedures are still not being used to treat Alzheimer's disease (AD) in day-to-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback